About Take, Test and Treat Webinar Series
BD has wanted to host an event like this for some time. With the shift in environment from real-life to virtual, this has given us a chance to expand our original theme, and look at other issues affecting blood cultures.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.
Looking at the blood culture pathway is relevant to all of us right now. The crossover in symptoms between coronavirus and sepsis, means early diagnosis is even more urgent. We are all moving away from the mentality of 'just in time' to 'just in case'.
Our speakers have been handpicked for their expertise in diagnostics, in clinical settings, and as known advocates for patient safety.
They will examine what methods and best practices are available, as well as reflecting on the current mood and change in priorities within healthcare. This is against a backdrop of UKI guidelines, the UK’s diagnostic strategy and what the future of blood cultures could look like.
You will have the chance to hear real life UK customer stories, and our final session will end with a panel discussion chaired by Ed Jones, former Chief of Staff to the UK Foreign Secretary, Jeremy Hunt MP. The panel features Lord O’Shaughnessy, and Dr Ron Daniels, and will tackle the issues around blood cultures and testing in the current COVID-19 climate.